This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2022-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2023
Title: Andrew Whittaker: Innovator in MPO Inhibitors
Introduction
Andrew Whittaker is a notable inventor based in Cambridge, GB. He has made significant contributions to the field of medicine, particularly through his work on MPO inhibitors. With a total of 2 patents, his innovations are paving the way for new therapeutic applications.
Latest Patents
Whittaker's latest patents focus on MPO inhibitors for use in medicine. The present disclosure relates to new therapeutic uses of MPO inhibitors and methods of treatment involving the same. This innovative approach has the potential to enhance treatment options in the medical field.
Career Highlights
Throughout his career, Andrew Whittaker has worked with prominent companies, including AstraZeneca AB. His experience in these organizations has allowed him to develop and refine his expertise in pharmaceutical innovations.
Collaborations
One of his notable collaborators is Hitesh Jayantilal Sanganee. Their partnership has contributed to the advancement of research and development in their field.
Conclusion
Andrew Whittaker's work on MPO inhibitors exemplifies the impact of innovation in medicine. His contributions are significant and continue to influence therapeutic practices.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile